Par Drugs and Chemicals Limited
PAR
Rank in Stocks
#27480
Par Drugs and Chemicals Limited is an Indian enterprise that focuses on the... Par Drugs and Chemicals Limited is an Indian enterprise that focuses on the creation, production, and sale of active pharmaceutical ingredients (APIs) and specialized chemicals. Its comprehensive product line features a diverse array of compounds, such as magnesium salts, dried aluminum hydroxide gel, sodium aluminum silicate, precipitated silica, magnesium silicate, colloidal silicon dioxide, sucralfate USP, as well as various amorphous and custom-blended formulations. The company also extends its market presence through international exports. Founded in 1982, Par Drugs and Chemicals Limited is headquartered in Vadodara, India.
Share Price
$1.20
Last synced: 2026-11-09
Market Cap
$14.82M
Change (1 day)
4.39%
Change (1 year)
8.38%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Par Drugs and Chemicals Limited (PAR)
Category
Healthcare
EPS for Par Drugs and Chemicals Limited (PAR)
EPS as of September 2026 TTM: $0.11
According to Par Drugs and Chemicals Limited's latest financial reports, its current EPS (TTM) is $0.11. At the end of 2025 the company had an EPS of $0.13, a decrease compared to its 2024 EPS of $0.14.
EPS history for Par Drugs and Chemicals Limited from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.11 | -14.69% |
| 2025 | $0.13 | -10.12% |
| 2024 | $0.14 | 26.05% |
| 2023 | $0.11 | 13.58% |
| 2022 | $0.10 | -23.55% |
| 2021 | $0.13 | 151.17% |
| 2020 | $0.05 | 74.83% |
| 2019 | $0.03 | 57.22% |
| 2018 | $0.02 | -19.05% |
| 2017 | $0.02 | 352.94% |
| 2016 | $0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 5,762.40% |
DE
|
|
| $6.08 | 5,380.25% |
DE
|
|
| $1.55 | 1,298.20% |
JP
|
|
| $3.66 | 3,200.27% |
CH
|
|
| $0.45 | 305.77% |
IL
|
Questions about Par Drugs and Chemicals Limited's earnings per share (EPS)
What is Par Drugs and Chemicals Limited's earnings per share (EPS)?
Par Drugs and Chemicals Limited's earnings per share (EPS) over the last twelve months is $0.11, as of Sep 2026.
What was Par Drugs and Chemicals Limited's earnings per share (EPS) in 2025?
In 2025, Par Drugs and Chemicals Limited's earnings per share (EPS) was $0.13, 7.14% less than in 2024 ($0.14).
How has Par Drugs and Chemicals Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Par Drugs and Chemicals Limited's earnings per share (EPS) went from $0.05 to $0.13, an average growth of 21.06% a year.
How does Par Drugs and Chemicals Limited's earnings per share (EPS) compare with similar companies?
Par Drugs and Chemicals Limited's earnings per share (EPS) ($0.11) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.